Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of PROSTATYPE GENOMICS AB
No Price
Closing Price XSTO 28.04.2026:
0,78 SEK
28.04.2026 13:42
Current Prices from PROSTATYPE GENOMICS AB
Exchange
Ticker
Currency
Last Trade
Price
Daily Change
NASDAQ STOCKHOLM AB
PROGEN.ST
SEK
28.04.2026 13:42
0,78 SEK
-0,03 SEK
-3,93 %
Share Float & Liquidity
Free Float94,83 %
Shares Float31,29 M
Shares Outstanding33 M
Company Profile for PROSTATYPE GENOMICS AB Share
Prostatype Genomics AB manufactures, markets, and sells the prognostic gene tests. It offers Prostatype Test System that combines gene expression information with used clinical parameters, such as PSA, Gleason Score, and Tumor Stage, as well as calculates the P-score. The test is based on database containing prostate cancer patients and provides decision support for patients and doctors when making a treatment decision. The company was founded in 2007 and is based in Solna, Sweden.
